RMX one step closer after partner elects to list


Published 16-NOV-2015 16:29 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Junior gold company Red Mountain Mining (ASX:RMX) is a step closer to funding of its Batangas Gold Project dreams after strategic partner Bluebird Merchant Ventures announced its intentions to list on the London Stock Exchange.

Bluebird is planning to list in early December, and the plan is to use cash from the IPO to fulfil a funding commitment covering the Batangas Gold Project in the Philippines.

RMX told its shareholders this morning that the timeline for the first part of the funding deal had been pushed back to December 8 at the latest to allow Bluebird to complete the listing.

At this stage the plan is for Bluebird to pay an initial $US1.7 million ($A2.4 million) in two tranches to allow Bluebird to take a 25% stake in Red Mountain Mining Singapore, the company which holds the promising gold project.

Exploration on the project will then be funded on a pro-rata basis, but Bluebird will have the option of bumping its stake up to 50.1% for another $1.7 million before September 30 next year.

However, should Bluebird not take up the extra stake it will still have an opportunity to do so, with Bluebird having to chip in $3.8 million to get the interest.

The cash from the two phases of funding will go toward a definitive feasibility study, permitting at the project, and drilling of new high-grade gold targets at the Lobo prospect.

About the Batangas Gold Project

The funding is going towards a definitive feasibility study and drilling at the Batangas Gold Project in the Philippines.

Total mineral resources at Batangas sit at 2.97 million tonnes @ 2.4 grams per tonne gold for 227,000 on an indicated basis, and 3.22MT @ 2.1g/t for 218,000oz on an inferred basis.

The Batangas Gold Project in the Philippines

The Lobo area features 82,000 oz on an indicated and inferred basis – including the South West Breccia mine, which will be the first start-up mine at the project.

Free cash flow from production of the first 100,000oz is expected to be $45 million – which recently got a boost by 50% due to increases in the Australia dollar gold price and a drop in the Philippine oil price.

Capex at this stage is expected to be $15 million, a figure set out in a scoping study and feasibility update, but a definitive feasibility study would add more certainty around the numbers.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free